2030년까지 북미 형질감염 시약 및 장비 시장 예측 - 지역 분석 - 제품별(시약 및 기기), 방법(바이러스 방법, 비바이러스 방법 및 하이브리드 방법), 응용 분야(생의학 연구, 단백질 생산 및 치료 전달), 및 최종 사용자(학술 및 연구 기관, 제약 및 생명공학 회사)
회사별 전략적 이니셔티브 연료 북미 형질감염 시약 및 장비 시장
북미 형질감염 시약 및 장비에서 운영되는 회사 협업, 확장, 계약, 파트너십 및 신제품 출시와 같은 전략적 개발에 시장 초점을 맞춰 판매를 개선하고 지리적 범위를 확장하며 기존 고객 기반보다 더 큰 규모의 서비스를 제공할 수 있는 역량을 강화합니다. 이러한 발전은 어느 정도 시장에 새로운 트렌드를 도입하는 데에도 기여합니다. 북미 형질감염 시약 및 장비 시장의 주목할만한 발전 중 일부는 아래에 언급되어 있습니다.
2023년 4월, Thermo Fisher Scientific은 가장 까다로운 세포 유형에서도 형질감염을 촉진하고 고효율, 세포 회수 및 재현성을 가능하게 하는 Invitrogen Neon NxT 전기천공 시스템을 출시했습니다. Neon NxT 전극은 최소한의 표면적을 제공하고 보다 균일한 전기장을 생성하며 형질감염 중에 적절한 생리학적 조건을 유지하도록 최적으로 배치되어 더 많은 세포에서 원하는 변형이 일어나도록 하고 프로세스 중에 손실되는 세포 수를 줄입니다. 새로운 시스템은 또한 개선된 피드백 루프와 사용 편의성을 위한 인체공학적 향상 기능을 갖추고 있습니다. 2021년 8월 Mirus Bio는 유전자 치료법 개발을 위한 바이러스 벡터 제조를 지원하기 위한 형질감염 시약과 강화제를 제공하는 TransIT VirusGEN GMP 제품 라인을 출시했습니다. TransIT VirusGEN GMP 형질감염 시약은 현탁액 및 부착 HEK 293 세포에 전달 백신 DNA의 전달을 향상시켜 재조합 AAV 및 LV 벡터의 생산을 보다 효율적으로 만들기 위해 개발되었습니다. 2020년 7월, Polyplus-transfection SA는 렌티바이러스 및 아데노 관련 바이러스(AAV) 생산의 전임상, 임상 및 상업적 공정 개발을 지원하도록 설계된 형질감염 시약의 PEIpro 제품 포트폴리오에 대한 최초의 GMP 준수 잔류 테스트를 시작했습니다. 세포치료와 유전자치료. 또한, Polyplus-transfection은 후기 단계 및 상용화 세포 및 유전자 치료법을 위한 PEIpro-GMP 제품에 대한 이중 소싱도 시작했습니다. 따라서 형질감염 시약 및 시스템과 같은 제품의 도입; 새롭거나 개선된 제품을 만들기 위해 다양한 건강 문제를 겨냥한 혁신적인 제품 개발; 그리고 시장에서 경쟁력을 유지하기 위한 새로운 사업의 개시는 모두 협력과 파트너십을 통해 형질감염 시약 및 장비를 위한 새로운 플랫폼의 개발을 가속화하는 데 도움이 될 수 있습니다.
북미 형질감염 시약 및 장비 시장 개요
세포 및 유전자 치료법(CGT)은 치료적 필요성이 해결되지 않은 심각하고 희귀한 질병으로 고통받는 환자를 치료하기 위해 처방됩니다. CGT 제조는 인프라와 전문성 부족이 주요 제한 요소인 매우 복잡한 프로세스입니다. 중간체 및 최종 제품과 관련된 물류 관련 문제도 기업의 CGT 제조 역량을 제한합니다. CGT 제조 공정에는 \'성분채집술\'을 통해 자가 세포를 추출한 후 전문 실험실로 보내고 다시 병원으로 보내 환자에게 투여하는 과정이 포함되며, 이 모든 과정은 엄격한 품질 관리를 통해 수행되어야 합니다. 미국 식품의약국(FDA)은 지금까지 7개의 CGT 약물만을 승인했으며 신제품 파이프라인은 ~1,200개의 실험 치료법에 도달했습니다. 이들 중 절반은 2상 임상시험에 있다. 이러한 전망으로 인해 2023년 화학 및 엔지니어링 뉴스 보고서에 따르면 세포 치료제와 유전자 치료제의 연간 매출은 각각 15%와 최대 30% 증가할 것으로 예상됩니다.
많은 제조업체가 계약 개발 제조 조직에 접근합니다. Labcorp, Lonza 및 Catalent와 같은 CDMO(CDMO)는 CGT 제품의 생산 및 상업화와 관련된 장벽을 극복합니다. Lonza는 세포 및 유전자 치료제 제조 역량을 강화하기 위해 미화 920만 달러를 투자했습니다. CDMO의 이러한 이니셔티브는 미국 내 형질감염 시약 및 장비 시장의 성장에 기여하고 있습니다.
또한 2022년 2월 혁신, 과학 및 산업부 장관인 François-Philippe Champagne는 캐나다 혁신 재단(CFI)을 통해 캐나다 정부에 4,500만 달러의 자금 지원을 발표했습니다. 연구팀은 세계적 수준의 연구를 수행하기 위해 적절한 실험실과 인프라를 갖추고 기술 부서에 접근할 수 있습니다. 캐나다 보건 연구소(CIHR)는 약물 발견 및 약물 개발을 가속화하기 위한 맞춤형 의학에 대한 새로운 협력 자금 지원 프로그램을 위해 퀘벡 약물 발견 컨소시엄(CQDM)과 파트너십을 맺었다고 발표했습니다.
2030년까지 북미 형질감염 시약 및 장비 시장 수익 및 예측(미화 백만 달러)
북미 형질감염 시약 및 장비 시장 세분화
북미 형질감염 시약 및 장비 시장은 제품, 방법, 애플리케이션, 최종 사용자 및 국가를 기준으로 분류됩니다.
제품을 기준으로 북미 형질감염 시약 및 장비 시장은 시약 및 기기로 구분됩니다. 2022년에는 시약 부문이 더 큰 점유율을 차지했습니다.
방법 측면에서 북미 형질감염 시약 및 장비 시장은 바이러스 방법, 비바이러스 방법, 하이브리드 방법으로 분류됩니다. 비바이러스 방법 부문은 2022년에 가장 큰 점유율을 차지했습니다. 바이러스 부문은 레트로바이러스, 아데노바이러스, 아데노 관련 바이러스 및 헤르페스 바이러스로 하위 분류됩니다. 비바이러스성 부분은 물리적/기계적 방법과 화학적 방법으로 구분됩니다. 또한 물리적/기계적 방법은 전기천공법, 미세주입법, 생물학적 방법, 레이저법, 자기감염법, 초음파천공법 등으로 세분화됩니다. 또한, 화학적 방법 부문은 리포솜 기반/고지질 기반 및 비리포솜/고지질 기반으로 하위 분류됩니다.
응용 분야에 따라 북미 형질주입 시약 및 장비 시장은 생물 의학 연구, 단백질 생산 및 치료 전달로 분류됩니다. 2022년에는 생의학 연구 부문이 가장 큰 점유율을 차지했습니다.
최종 사용자를 기준으로 북미 형질감염 시약 및 장비 시장은 학계 및 연구 기관과 제약 및 생명공학 회사로 구분됩니다. 2022년에는 학계 및 연구 기관 부문이 더 큰 점유율을 차지했습니다.
국가별로 북미 형질감염 시약 및 장비 시장은 미국, 캐나다, 멕시코로 분류됩니다. 2022년 북미 형질주입 시약 및 장비 시장은 미국이 장악했습니다.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc 및 Polyplus-Transfection SA는 북미 형질감염 시약 및 장비 시장에서 활동하는 선도적인 회사입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 North America Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - North America Market Analysis
5.1 North America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 North America Transfection Reagents and Equipment Market Forecast Analysis
6. North America Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Transfection Reagents and Equipment Market -Country Analysis
10.1 North America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1 North America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 United States: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.1.2 United States: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.1.2.1 United States: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.1.2.2 United States: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.1.2.2.1 United States: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.1.2.2.2 United States: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.1.3 United States: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.1.4 United States: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.2 Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Canada: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Canada: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 Mexico: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 Mexico: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Polyplus-Transfection SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. North America Transfection Reagents and Equipment Market Segmentation
Table 2. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. North America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. North America Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. North America Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. North America Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. North America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. North America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.